Oncolytic Virotherapy Platform Designed to Target All Tumor Sites: we will have some news soon, oncolytics are very promising (CLD-201)

[Maxone73]

– Preclinical models have demonstrated the ability to resist oncolytic virus inactivation by human serum and target diverse tumor types

– Novel therapeutic approach allows for ease of administration, increased cost-effectiveness, and the ability to reach a broad patient population

Enough for me to get very interested!! Keep an eye on CLD-201

Sorry I should not post links to press releases but I could not find other better sources

calidibio.com/newsroom/post...

[DAR1890]

very interesting! Thanks for sharing!